Kirby Lester Revenue and Competitors
Estimated Revenue & Valuation
- Kirby Lester's estimated annual revenue is currently $7M per year.
- Kirby Lester's estimated revenue per employee is $251,000
Employee Data
- Kirby Lester has 28 Employees.
- Kirby Lester grew their employee count by 8% last year.
Kirby Lester's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Technical Support Engineer | Reveal Email/Phone |
Kirby Lester Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $63.5M | 253 | 6% | N/A | N/A |
#2 | $13.6M | 54 | 10% | N/A | N/A |
#3 | $9.8M | 39 | 0% | N/A | N/A |
#4 | $1.5M | 6 | -60% | N/A | N/A |
#5 | $21.1M | 84 | -3% | N/A | N/A |
#6 | $38.4M | 153 | -1% | N/A | N/A |
#7 | $114.2M | 455 | 4% | N/A | N/A |
#8 | $45.9M | 183 | -6% | N/A | N/A |
#9 | $12450M | 38512 | 1% | $1.7B | N/A |
#10 | $4.3M | 17 | -60% | N/A | N/A |
What Is Kirby Lester?
Kirby Lester was established in 1971 and maintains the largest market share of automatic tablet counter sales in the USA and Canada. More KL15 counters are used to dispense prescriptions in chains, hospitals and retail pharmacies, than any other automated counting system: over 20,000 pharmacies rely on us for their counting needs.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$7M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kirby Lester News
Kirby Lester, Cerner, Talyst, ScriptPro, TCGRx,. Parata, Innovation, Willach Group, Swisslog, and YUYAMA. This Pharmacy Automation Market report...
Kirby Lester, Cerner, Talyst, ScriptPro, TCGRx,. Parata, Innovation, Willach Group, Swisslog, and YUYAMA. The report provides a good overview of...
Ocelco, Kirby Lester, PharmaSystems, Torbal Scales, Capsa Healthcare, RX Count Corporation, Teller Metrics, Key International,...
Other Companies in Lake Forest
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.3M | 28 | 4% | N/A |
#2 | N/A | 28 | 40% | N/A |
#3 | $5.7M | 28 | 8% | N/A |
#4 | $5.7M | 28 | 0% | N/A |
#5 | N/A | 29 | 0% | N/A |